<?xml version="1.0" encoding="UTF-8"?><mods xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" ID="id-E7-23413">
    <name type="corporate">
        <namePart>United States Government Publishing Office</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">publisher</roleTerm>
            <roleTerm authority="marcrelator" type="code">pbl</roleTerm>
        </role>
        <role>
            <roleTerm authority="marcrelator" type="text">distributor</roleTerm>
            <roleTerm authority="marcrelator" type="code">dst</roleTerm>
        </role>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>National Archives and Records Administration</namePart>
        <namePart>Office of the Federal Register</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">author</roleTerm>
            <roleTerm authority="marcrelator" type="code">aut</roleTerm>
        </role>
        <description>Government Organization</description>
    </name>
    <typeOfResource>text</typeOfResource>
    <genre authority="marcgt">government publication</genre>
    <language>
        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
    </language>
    <extension>
        <collectionCode>FR</collectionCode>
        <category>Regulatory Information</category>
        <waisDatabaseName>2007_register</waisDatabaseName>
        <branch>executive</branch>
        <dateIngested>2010-09-22</dateIngested>
    </extension>
    <genre authority="marcgt">article</genre>
    <titleInfo>
        <title>Definition of “Positional Isomer” as It Pertains to the Control of Schedule I Controlled Substances</title>
        <partName>Rules and Regulations</partName>
    </titleInfo>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2007-12-03/html/E7-23413.htm">
        <identifier type="FDsys Unique ID">D09002ee1c809d162</identifier>
    </relatedItem>
    <relatedItem type="otherFormat" xlink:href="https://www.govinfo.gov/content/pkg/FR-2007-12-03/pdf/E7-23413.pdf">
        <identifier type="FDsys Unique ID">D09002ee1c809d210</identifier>
    </relatedItem>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Department of Justice</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <name type="corporate">
        <namePart>United States</namePart>
        <namePart>Drug Enforcement Administration</namePart>
        <role>
            <roleTerm authority="marcrelator" type="text">originator</roleTerm>
            <roleTerm authority="marcrelator" type="code">org</roleTerm>
        </role>
        <description>United States Government Agency or Subagency</description>
    </name>
    <abstract>On May 25, 2006, DEA published a Notice of Proposed Rulemaking which proposed the addition of a specific definition for the term "positional isomer" to allow for the systematic determination of which isomers of schedule I substances would be considered to be "positional," and therefore, subject to schedule I control. This rulemaking finalizes that definition. The Controlled Substances Act (CSA) and its implementing regulations specify which hallucinogenic substances are considered schedule I controlled substances. The CSA states that all salts, isomers, and salts of isomers of these substances are also schedule I controlled substances. In non-technical terms, an isomer of a substance is a different compound, but a compound which has the same number and kind of atoms. The terms "optical isomer" and "geometric isomer" are specific scientific terms and it is easy to determine whether one substance is an optical or geometric isomer of another. The term "positional isomer," however, is subject to scientific interpretation. The addition of a definition for the term "positional isomer" will assist legitimate research[ers] and industry in determining the control status of materials that are "positional isomers" of schedule I hallucinogens. While the DEA will remain the authority for ultimately determining the control status of a given material, providing a specific definition for "positional isomer" will ensure consistent criteria are utilized in making these determinations. This rule does not change existing laws, regulations, policies, processes, and procedures regarding the determination of control status for schedule I hallucinogenic substances. This rule merely makes available to the public the longstanding definition of "positional isomer" which DEA has used when making these scheduling determinations. This rule is relevant only to specialized forensic or research chemists. Most of these individuals are existing DEA registrants who are authorized by the DEA to handle schedule I hallucinogenic substances.</abstract>
    <identifier type="FR citation">72 FR 67850</identifier>
    <identifier type="uri">https://www.govinfo.gov/app/details/FR-2007-12-03/E7-23413</identifier>
    <identifier type="FR Doc No.">E7-23413</identifier>
    <identifier type="former granule identifier">fr03de07-6</identifier>
    <identifier type="Regulation ID Number">RIN 1117-AA94</identifier>
    <identifier type="billing code">4410-09-P</identifier>
    <identifier type="department code">Docket No. DEA-260F</identifier>
    <location>
        <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2007-12-03/E7-23413</url>
        <url access="raw object" displayLabel="HTML rendition">https://www.govinfo.gov/content/pkg/FR-2007-12-03/html/E7-23413.htm</url>
        <url access="raw object" displayLabel="PDF rendition">https://www.govinfo.gov/content/pkg/FR-2007-12-03/pdf/E7-23413.pdf</url>
    </location>
    <subject>
        <topic>Controlled Substances</topic>
        <topic>Definitions</topic>
        <topic>Drug Traffic Control</topic>
    </subject>
    <physicalDescription>
        <extent>3 p.</extent>
    </physicalDescription>
    <part type="Rules and Regulations">
        <extent unit="pages">
            <start>67850</start>
            <end>67852</end>
        </extent>
    </part>
    <identifier type="preferred citation">72 FR 67850</identifier>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Code of Federal Regulations</title>
            <partNumber>Title 21 Part 1300</partNumber>
        </titleInfo>
        <identifier type="CFR citation">21 CFR Part  1300</identifier>
    </relatedItem>
    <relatedItem type="isReferencedBy">
        <titleInfo>
            <title>Regulation Identification Number 1117-AA94</title>
        </titleInfo>
        <identifier type="regulation ID number">RIN 1117-AA94</identifier>
    </relatedItem>
    <extension>
        <searchTitle>Definition of “Positional Isomer” as It Pertains to the Control of Schedule I Controlled Substances; Federal Register Vol. 72, Issue </searchTitle>
        <granuleClass>RULE</granuleClass>
        <accessId>E7-23413</accessId>
        <agency order="1">DEPARTMENT OF JUSTICE</agency>
        <agency order="2">Drug Enforcement Administration</agency>
        <effectiveDate>2008-01-02</effectiveDate>
        <departmentDoc>Docket No. DEA-260F</departmentDoc>
        <rin number="1117-AA94"/>
        <billingCode>4410-09-P</billingCode>
        <frDocNumber>E7-23413</frDocNumber>
        <action>Final Rule.</action>
        <summary>On May 25, 2006, DEA published a Notice of Proposed Rulemaking which proposed the addition of a specific definition for the term "positional isomer" to allow for the systematic determination of which isomers of schedule I substances would be considered to be "positional," and therefore, subject to schedule I control. This rulemaking finalizes that definition. The Controlled Substances Act (CSA) and its implementing regulations specify which hallucinogenic substances are considered schedule I controlled substances. The CSA states that all salts, isomers, and salts of isomers of these substances are also schedule I controlled substances. In non-technical terms, an isomer of a substance is a different compound, but a compound which has the same number and kind of atoms. The terms "optical isomer" and "geometric isomer" are specific scientific terms and it is easy to determine whether one substance is an optical or geometric isomer of another. The term "positional isomer," however, is subject to scientific interpretation. The addition of a definition for the term "positional isomer" will assist legitimate research[ers] and industry in determining the control status of materials that are "positional isomers" of schedule I hallucinogens. While the DEA will remain the authority for ultimately determining the control status of a given material, providing a specific definition for "positional isomer" will ensure consistent criteria are utilized in making these determinations. This rule does not change existing laws, regulations, policies, processes, and procedures regarding the determination of control status for schedule I hallucinogenic substances. This rule merely makes available to the public the longstanding definition of "positional isomer" which DEA has used when making these scheduling determinations. This rule is relevant only to specialized forensic or research chemists. Most of these individuals are existing DEA registrants who are authorized by the DEA to handle schedule I hallucinogenic substances.</summary>
        <dates>Effective January 2, 2008.</dates>
        <contact>Christine A. Sannerud, Ph.D., Chief, Drug and Chemical Evaluation Section, Office of Diversion Control, Drug Enforcement Administration, Washington, DC 20537 at (202) 307-7183.</contact>
        <cfr title="21">
                                    
            <part number="1300"/>
                                    
            <subject>Controlled Substances</subject>
                                    
            <subject>Definitions</subject>
                                    
            <subject>Drug Traffic Control</subject>
                                
        </cfr>
        <tocSubject1>Schedules of controlled substances:</tocSubject1>
        <tocDoc>Schedule I controlled substances; positional isomer definition, </tocDoc>
    </extension>
    <relatedItem type="host" ID="P0b002ee18093f08d" xlink:href="https://www.govinfo.gov/metadata/pkg/FR-2007-12-03/mods.xml">
        <titleInfo>
            <title>Federal Register</title>
            <partNumber>Vol. 72, no. 231</partNumber>
        </titleInfo>
        <originInfo>
            <publisher>Office of the Federal Register, National Archives and Records Administration</publisher>
            <dateIssued encoding="w3cdtf">2007-12-03</dateIssued>
            <issuance>continuing</issuance>
            <frequency>daily</frequency>
        </originInfo>
        <physicalDescription>
            <note type="source content type">deposited</note>
            <digitalOrigin>born digital</digitalOrigin>
            <extent>222 p.</extent>
        </physicalDescription>
        <tableOfContents xlink:href="https://www.govinfo.gov/app/frtoc/2007-12-03">    
		  Table of Contents: 
		</tableOfContents>
        <classification authority="sudocs">AE 2.7:</classification>
        <classification authority="sudocs">GS 4.107:</classification>
        <classification authority="sudocs">AE 2.106:</classification>
        <classification authority="lcc">KF70.A2</classification>
        <identifier type="uri">https://www.govinfo.gov/app/details/FR-2007-12-03</identifier>
        <identifier type="local">P0b002ee18093f08d</identifier>
        <identifier type="issn">0097-6326</identifier>
        <identifier type="issn">0042-1219</identifier>
        <identifier type="issn">0364-1406</identifier>
        <identifier type="stock number">769-004-00000-9</identifier>
        <identifier type="ILS system id">000582072</identifier>
        <identifier type="former identifier">f:fr03de07</identifier>
        <location>
            <url displayLabel="Content Detail" access="object in context">https://www.govinfo.gov/app/details/FR-2007-12-03</url>
            <url displayLabel="PDF rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2007-12-03/pdf/FR-2007-12-03.pdf</url>
            <url displayLabel="XML rendition" access="raw object">https://www.govinfo.gov/content/pkg/FR-2007-12-03/xml/FR-2007-12-03.xml</url>
        </location>
        <accessCondition type="GPO scope determination">fdlp</accessCondition>
        <part type="issue">
            <extent unit="pages">
                <start>67831</start>
                <end>68039</end>
            </extent>
        </part>
        <recordInfo>
            <recordContentSource authority="marcorg">DGPO</recordContentSource>
            <recordCreationDate encoding="w3cdtf">2010-09-22</recordCreationDate>
            <recordChangeDate encoding="w3cdtf">2024-06-05</recordChangeDate>
            <recordIdentifier source="DGPO">FR-2007-12-03</recordIdentifier>
            <recordOrigin>machine generated</recordOrigin>
            <languageOfCataloging>
                <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
            </languageOfCataloging>
        </recordInfo>
        <extension>
            <docClass>FR</docClass>
            <accessId>FR-2007-12-03</accessId>
            <volume>72</volume>
            <issue>231</issue>
        </extension>
    </relatedItem>
</mods>
